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Abstract 
Background: Persea major Kopp (Lauraceae) is a plant with wound healing, antibacterial, and analgesic properties. 
The aim of this study was to assess the in vitro antibacterial activity of the concentrated crude extract (CCE) and ethyl 
acetate fraction (EAF) of this plant against Enterococcus faecalis and compare it with calcium hydroxide [Ca(OH)2] paste 
and 2% chlorhexidine digluconate (CHX).
Methods: The plant material was collected, and an extract was prepared according to the requirements of the study 
(CCE and EAF). The minimum inhibitory concentrations (MICs) of CCE, EAF, Ca(OH)2, Ca(OH)2 + CCE, and CHX against 
E. faecalis were determined using the broth microdilution method
Results: The EAF inhibited E. faecalis at concentrations of 166.50, 83.25, and 41.62 mg mL−1, and 1.00, 0.50, and 0.25% 
of CHX solutions showed antimicrobial activity. The MICs of Ca(OH)2 paste were 166.50 and 83.25 mg mL
−1, whereas 
Ca(OH)2 + CCE showed antimicrobial activity only at a concentration of 166.50 mg mL−1. CCE showed no inhibitory 
effect at any of the concentrations tested
Conclusions: The CCE did not show any antimicrobial activity against E. faecalis; however, the EAF was the most 
effective among the three highest concentrations tested.
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Background
The aim of an endodontic treatment is to eliminate bac-
teria and their by-products from the root canal system 
[1]. The indiscriminate use of antibiotics has increased 
antimicrobial resistance, which results in the persis-
tence infections and a decrease in the effectiveness of 
drug therapy [2]. In Endodontics, one of the pathogens 
associated with the development and maintenance of the 
infectious process and failure of therapy is Enterococcus 
faecalis [3].
The effect of substances against E. faecalis, as calcium 
hydroxide [Ca(OH)2] [4–6] and 2% chlorhexidine diglu-
conate (CHX) [6] is limited, even when they are used 
in combination [7]. Alternative antimicrobial products 
and drugs of plant origin are promising candidates to 
overcome this problem. Previous studies have exam-
ined the effects of natural substances against E. faeca-
lis [8–14]. Persea major Kopp (Lauraceae) is one with 
antimicrobial potential. It is native to Brazil, commonly 
known as “pau-andrade;” and has shown wound heal-
ing, antibacterial, and analgesic effects [15]. The species 
of the genus Persea are characterized by the presence 
of benzil tetrahydroisoquinolines alkaloids, flavonoids 
(keampferol and kaempferol-3-rhamnoside, quercetin 
and quercetin-3-rhamnoside; flavan-3,4-diol: leucocya-
nidins and flavan-3-ol: (±)-catechin) [16]. Other authors 
isolated and characterized the leaves of Persea obovati-
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obovaten [2-(3,4-dihydroxy-5-methoxyphenyl)-7-meth-
oxy-3- methyl-5-trans-propenyl benzofuran], perseal C 
[(2S,3R)-2,3-dihydro-2-(3,4-methylenedioxyphenyl)-5- 
formyl-3-hydroxymethyl-7-methoxy benzofuran] and 
perseal D [2-(3,4-dihydroxy-5-methoxyphenyl)-5-for-
myl-7- methoxy-3-methyl benzofuran]. These new neol-
ignans, P-388, KB16, A549, and HT-29, showed cytotoxic 
action against cancer cells [17]. The presence of tannins 
was found in Persea americana leaves [17–19] and in seeds 
[20, 21]. Phytochemical analysis showed that it has a num-
ber of compounds, especially the tannins, that precipitate 
proteins [22] and have antibacterial, antiseptic, antifungal, 
and hemostatic properties [23]. In Endodontics the use of 
derivatives from this plant is still unknown.
Therefore, this study aimed to examine the antimicro-
bial activity of extracts from the bark of P. major (con-
centrated crude extract, CCE and ethyl acetate fraction, 
EAF) against E. faecalis by using the broth microdilution 
technique followed by determination of the minimum 
inhibitory concentrations (MICs). In addition, we com-
pared the antimicrobial effect of these extracts with that 
of Ca(OH)2, Ca(OH)2 + CCE, and 2% CHX.
Methods
Collection and identification of plant material
Samples of the bark of P. major were collected from an 
adult plant in the rural region of the municipality of 
Campo Largo, Paraná, Brazil. It was not necessary per-
mission to carry out sampling. For the identification of 
the plant material, we created herbarium specimens and 
deposited them in the Herbarium of the Positivo Univer-
sity (Registry Number 100).
The steps for preparation and fractionation of extracts 
are presented in Fig. 1.
The plant material was dried in a forced air oven at 
40 °C until the weight stabilized. Then, it was crushed to 
a powder, and thus, we obtained the pulverized drug for 
preparation of the crude ethanolic extract.
Obtaining plant extracts
Plant extracts were obtained according to Younes et  al. 
[24]. We blended the material by using an industrial tur-
bine (Rodrimar, São Paulo, SP, Brazil). We used 187.11 g 
of the dried and pulverized bark and 2000 mL of 70% eth-
anol (Rioquímica, São José do Rio Preto, SP, Brazil). This 
material was extracted for 20 min and the liquid obtained 
was filtered in vacuum, resulting in the crude ethanolic 
extract (approximately 2050 mL).
The concentration of the extract was performed in a 
rotary evaporator (Quimis, Diadema, SP, Brazil). Each 
cycle lasted for approximately 30  min, and the rotation 
speed was adjusted to six to obtain the CCE.
Fractionation of the CCE (liquid–liquid partition)
Liquid–liquid partition [25] was performed using the 
CCE and 2000  mL of ethyl acetate (Vetec, Duque de 
Caxias, RJ, Brazil). We placed 100  mL of the CCE in a 
separation funnel, and then, an equivalent volume of 
ethyl acetate (100 mL) was poured on it with gentle agi-
tation. This step was repeated nine times, until the sol-
vent was clear. Thus, we obtained the EAF, which was 
then concentrated in a rotary evaporator and stored in 
an amber flask.
Preparation of the crude 
ethanolic extract




Liquid-liquid partition Preparation before
lyophilization (freezing)
Ethyl acetate fraction
Concentration of ethyl 







microdilution in plate and 
MIC
Fig. 1 Steps used to assess the antimicrobial efficacy of the extracts 
from the Persea major Kopp (Lauraceae)
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Freezing and lyophilization
The extracts were frozen in autoclaved plastic containers 
and covered with a plastic wrap for 48  h. Microperfora-
tions were introduced in the wrap using a sterilized gingi-
val needle to allow the sublimation of the liquid. Then, the 
samples were placed in a lyophilizer (Ilsinh Lab. Co., Ltd., 
Korea). Any residual liquid was removed, and the sample 
was frozen again until the sample dried completely. The 
lyophilization process was completed in 7 days.
Preparation of the drug for the analysis of antimicrobial 
activity
The samples were powdered using a glass rod. Visual 
inspection allowed the granulometric analysis of the 
preparations, which were weighed in mini Petri dishes in 
a precision balance. For preparing drug samples, 500 mg 
lyophilized powders from the CCE, EAF, and Ca(OH)2 P. 
A. (Biodinâmica, Ibiporã, PR, Brazil), and 0.1 mL of 2% 
CHX solution (chlorhexidine S 2%—FGM, Joinville, SC, 
Brazil), were used.
The propylene glycol was the vehicle for treatment of 
the powder samples and for experiments because of its 
harmless characteristics and the common use in endo-
dontic treatments.
Two samples from P. major were very viscous, which 
hampered pipetting. Therefore, 0.05 mL of sterile saline 
solution were added to them, including the Ca(OH)2 
paste. No vehicle was required for the 2% CHX solution.
Determination of the MIC by using the broth microdilution 
technique
We used the E. faecalis strain (ATCC 19433) and the 
Mueller–Hinton broth as the culture medium, with a pH 
between 7.2 and 7.4, at 25 °C. The bacterial inoculum was 
prepared according to standardized methods [26].
The bacterial strain was transferred from the mainte-
nance medium into a tube containing the brain heart infu-
sion (BHI) and kept at 35 °C for 18 h for strain activation. 
To isolate young colonies, we transferred aliquots into a 
Petri dish containing Muller-Hinton agar, and incubated it 
at 35 °C for 24 h. Then, 4–5 colonies were transferred into 
a tube containing 5  mL of sterile saline solution (0.85%) 
followed by homogenization in a vortex mixer for 15 s.
The turbidity of the cell suspension was adjusted to 
obtain an optical density similar to the 0.5 McFarland 
standard, which corresponds to a suspension containing 
approximately 1 to 2 × 108 cells mL−1. Subsequently, this 
solution was diluted (1:10) to obtain an inoculum con-
taining 107 cells mL−1.
The antimicrobial activity was examined using the broth 
microdilution technique [26] with modifications. The 
method comprised preparation of successive dilutions 
of each treatment to be assessed—CCE, EAF, Ca(OH)2 
solution, Ca(OH)2 solution with CCE, and 2% CHX—in 
a liquid culture medium, inoculation of the bacteria, and 
after incubation, interpretation of the result for determin-
ing the MIC.
The treatments were placed in 96 well microplates 
(TPP Cultilab; Campinas, SP, Brazil). The treatments 
were diluted to obtain a final concentration in each well 
from 166.50 to 2.6 μg mL−1 for the solutions, and from 1 
to 0.01% for the CHX. Then, 100 μL (0.1 mL) of the inoc-
ulum suspension to the wells was added. The columns 
were filled with suspensions as follows: microdilutions of 
the treatments, culture media control (negative control), 
controls for the treatments, and control for E. faecalis 
viability (positive control). Five test wells were repeated 
in each group.
The plates were incubated at 35  °C for 24 h and were 
read visually to determine the MIC. When bacterial 
growth was confirmed, suspensions from each well were 
transferred into Petri dishes identified and containing 
nutrient agar. After incubation at 35 °C for 48 h, the pres-
ence or absence of bacterial growth was evaluated. The 
MIC was regarded as the lowest concentration in the 
series of dilutions, which did not permit the growth of 
the susceptible bacteria [9]. So, to determine the MIC, 
we compared the bacterial growth in each well with that 
in the positive control and that observed in the nutrient 
agar dishes.
The concentration of the powder products tested was 
determined by calculating the concentration of the 
stock standard solution, by using the following formula: 
amount of product (mg)/volume of the vehicle (mL); 
thus, 550 mg/1.5 mL ≈ 333 mg mL−1.
Calculation of constant concentrations and volumes 
was used to determine the initial concentration of the 
products tested (concentration of the stock standard 
solution). To calculate the concentration of each dilution, 
we used the equation of constant concentration and vol-
ume (C1 × V1 = C2 × V2). We used the same volume in 
all wells, and thus, the dilution in each subsequent well 
was half of that in the previous well; we successively filled 
all wells in this manner (with the lower concentration 
tested).
Results
The MICs of the treatments are shown in Table 1.
The CCE did not inhibit bacterial growth at any of 
the concentrations tested. Contrary, all the other acted 
at various concentrations. The EAF inhibited bacterial 
growth at three highest concentrations (166.50, 83.25, 
and 41.62 mg mL−1). The same was observed with 1.00, 
0.50, and 0.25% of CHX solutions. Ca(OH)2  +  CCE 
showed antimicrobial activity only at its highest concen-
tration, 166.50 mg mL−1.
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Discussion
This study aimed to compare the antibacterial activ-
ity of the CCE and EAF from P. major, Ca(OH)2, 
Ca(OH)2  +  CCE, and CHX against E. faecalis. We 
observed satisfactory antimicrobial activity with the 
treatments, in particular the EAF, but the same was not 
observed with CCE.
Extensive research has been performed to identify sub-
stances that enable elimination of microorganisms from 
the root canal. However, therapeutic failure continues to 
occur in patients with persistence of the infection. Thus, 
we selected E. faecalis, a highly resistant bacterium, for 
this study [3].
The antimicrobial activity of substances described in 
previous studies, such as Ca(OH)2 [4–6] and CHX [6], 
including their combinations against this bacterium war-
rants further clarifications [7]. Ca(OH)2 is one of the 
most frequently used drugs in microbiological studies 
and in the field of Endodontics [4]. Some authors suggest 
that the effect of this drug against E. faecalis is low [6, 
27]. Treatment with Ca(OH)2 showed antibacterial activ-
ity only at two of its highest concentrations (166.50 and 
83.25 mg mL−1). This may be explained by the fact that 
E. faecalis is not sensitive to alkaline environment [28]. A 
study showed that the release of hydroxyl ions does not 
have sufficient antimicrobial activity against microorgan-
isms [29].
The 2% CHX has been considered superior to Ca(OH)2 
as an intracanal medication [30]. A recent study showed 
that the antimicrobial activity of CHX is increased when 
used in combination with Ca(OH)2 [31]. Our results 
showed that CHX was effective against E. faecalis at con-
centrations of 1, 0.5, and 0.25%. Our findings are con-
sistent with those that observed antimicrobial effect at 
1 and 0.5% of CHX [32]. Arias-Moliz et  al. [33] found 
low efficacy of 2% CHX in the elimination of E. faecalis, 
while other authors reported that 2% CHX used as an 
intracanal drug eliminated E. faecalis from the root canal 
system [34].
In the recent years, studies are being performed to iden-
tify and examine active principles from medicinal plants 
for use in dentistry against E. faecalis. Morinda citrifolia 
[8], Triphala [9], berberina [10], Syzygium aromaticum, 
Ocimum sanctum and Cinnamomum zeylanicum [11], 
Myrtus communis [12], Ferula gummosa [13], and oregano 
[14] have shown promising results. We used P. major in 
this study; the antimicrobial potential of some of the bio-
active components present in the different parts of this 
plant has been examined in a previous study [15]. Among 
these components, tannins, in particular the condensed 
tannins, have diverse important biological effects such 
as antimicrobial, antiseptic, and antifungal effects [23]. 
Tannins are phenolic compounds soluble in water, with 
molecular weight about 500–3000 Da, with ability to form 
insoluble complexes in water with proteins, gelatins and 
alkaloids [35]. This compound is responsible for the sen-
sation of astringency caused by certain food, due to the 
interaction with the salivary proline-rich proteins (PRPs) 
in the oral cavity. The tannin-induced interaction and/
or precipitation of proteins occur, probably, by means of 
hydrogen bridges between the phenolic groups of tannins 
and attachment sites of proteins [36]. Metals and enzymes 
easily influence the oxidation of tannins, thus the search-
ing for these plant compounds can be performed by add-
ing, for example, ferric chloride, lead acetate and gelatin, 
which promote the color change of the solutions and the 
formation of precipitates [37].
Few studies have evaluated the antimicrobial poten-
tial of this plant and its application; therefore, investiga-
tions are required to determine the antibacterial activity 
of P. major extracts against E. faecalis and to detect the 
concentrations responsible for the inhibition of bacte-
rial growth, including research in dentistry. Our results 
showed that the CCE had a low potential of inhibiting 
Table 1 Minimum inhibitory concentrations (MICs) of treatments against Enterococcus faecalis
(+) bacterial growth, (−) no bacterial growth, CCE concentrated crude extract, EAF ethyl acetate fraction, Ca(OH)2 calcium hydroxide, CHX chlorhexidine digluconate
Treatments MIC (mg mL−1)
166.50 83.25 41.62 20.81 10.40 5.20 2.60
CCE + + + + + + +
EAF − − − + + + +
Ca(OH)2 − − + + + + +
Ca(OH)2 + CCE − + + + + + +
MIC (%)
1.00 0.50 0.25 0.12 0.06 0.03 0.01
CHX − − − + + + +
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E. faecalis, such as the combination of Ca(OH)2 + CCE. 
However, promising results were observed with the EAF.
We used the microdilution technique, because this 
method was used in studies performed examining the effect 
of M. citrifolia as an irrigant solution [8], in an analysis of 
Triphala [9], and berberine [10] against E. faecalis. The 
MIC has been used in dentistry studies involving the analy-
sis of antimicrobial effect of plant products [9, 10]. In this 
study, the MIC was determined by observing the growth of 
E. faecalis in Petri dishes containing nutrient agar.
Although the compounds have been extracted from the 
same plant, different effects were found on E. faecalis. We 
suggest that this may have occurred because of the CCE 
have all the secondary metabolites present, while the EAF 
was a fraction which aimed the action of phenolic com-
pounds, especially the tannins. Our results showed that 
the EAF from P. major inhibited the growth of E. faecalis. 
The extract from this plant may be a promising alterna-
tive treatment for fighting microorganisms involved in 
endodontic infections.
We have registered a patent (BR 10 2012 028509 6) for 
using this plant for its wound healing, anti-inflammatory, 
and antimicrobial activities in dental care.
Limitations of this study are due to the fact that we 
have evaluated the action of different substances on only 
one microorganism. More studies are required to be veri-
fied behavior through the biofilm and tissue effects.
Conclusions
The CCE did not show antimicrobial activity against E. 
faecalis, and the EAF was the most effective among the 
three highest concentrations studied.
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